BDXA

Stats

Summary

Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded in 1897 and is headquartered in Franklin Lakes, NJ.

Market Cap: 16.1 Billion

Primary Exchange: New York Stock Exchange

Website: http://www.bd.com

Shares Outstanding: 271 Million

Float:

Dividend: 3.0624 (0.05%)

Beta: 0.588062107678645

Sector: Health Technology

Industry: Medical Specialties

Ethical Flags

Longest drawdown: 336 trading days

From: 2018-10-02 To: 2020-01-10

Lowest Point: